Long term changes in thrombocytopenia and leucopenia after HCV eradication with direct-acting antivirals

被引：0
|
作者：
Kazuto Tajiri
Kazuhiko Okada
Hiroyuki Ito
Kengo Kawai
Yoshiro Kashii
Yoshiharu Tokimitsu
Nozomu Muraishi
Aiko Murayama
Yuka Hayashi
Masami Minemura
Terumi Takahara
Yukihiro Shimizu
Ichiro Yasuda
机构：
[1] University of Toyama,Third Department of Internal Medicine, Faculty of Medicine
[2] Gastroenterology,undefined
[3] Toyama Red Cross Hospital,undefined
[4] Gastroenterology,undefined
[5] Takaoka Municipal Hospital,undefined
[6] Gastroenterology,undefined
[7] Nanto Municipal Hospital,undefined
[8] Gastroenterology,undefined
[9] Saiseikai Toyama Hospital,undefined
来源：
BMC Gastroenterology | / 23卷
关键词：
Hepatitis C virus; Thrombocytopenia; Hypersplenism; Direct-acting antiviral;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals
    Naggie, Susanna
    Sulkowski, Mark S.
    GASTROENTEROLOGY, 2012, 142 (06) : 1324 - +
  • [22] Treatment with direct-acting antivirals in a multicenter cohort of HCV-infected inmates in Italy
    Pontali, Emanuele
    Fiore, Vito
    Ialungo, Anna Maria
    Ranieri, Roberto
    Mollaretti, Oscar
    Barbarini, Giorgio
    Marri, Daniele
    Prestileo, Tullio
    Dell'Isola, Serena
    Rastrelli, Elena
    Leo, Guido
    Starnini, Giulio
    Babudieri, Sergio
    Madeddu, Giordano
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2018, 59 : 50 - 53
  • [23] Treatment of HCV in Renal Disease: Subtle Management Considerations in the Era of Direct-Acting Antivirals
    Yuval A. Patel
    Andrew J. Muir
    Current Hepatology Reports, 2016, 15 (4) : 285 - 290
  • [24] After the Direct-acting Antivirals Are Gone, There Is Still Work to Be Done in the Liver
    Kwo, Paul Y.
    Lacerda, Marco A.
    GASTROENTEROLOGY, 2016, 151 (04) : 582 - 584
  • [25] HCV cirrhotic patients treated with direct-acting antivirals: Detection of tubular dysfunction and resolution after viral clearance
    Biliotti, Elisa
    Palazzo, Donatella
    Tinti, Francesca
    D'Alessandro, Maria Domenica
    Esvan, Rozenn
    Labriola, Raffaella
    Cappoli, Andrea
    Umbro, Ilaria
    Volpicelli, Lorenzo
    Bachetoni, Alessandra
    Villa, Erica
    Mitterhofer, Anna Paola
    Rucci, Paola
    Taliani, Gloria
    LIVER INTERNATIONAL, 2021, 41 (01) : 158 - 167
  • [26] Update on hepatitis C: Direct-acting antivirals
    Leon L Seifert
    Ryan B Perumpail
    Aijaz Ahmed
    World Journal of Hepatology, 2015, (28) : 2829 - 2833
  • [27] HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
    Brochado-Kith, Oscar
    Martinez, Isidoro
    Berenguer, Juan
    Gonzalez-Garcia, Juan
    Salguero, Sergio
    Sepulveda-Crespo, Daniel
    Diez, Cristina
    Hontanon, Victor
    Ibanez-Samaniego, Luis
    Perez-Latorre, Leire
    Fernandez-Rodriguez, Amanda
    angeles Jimenez-Sousa, Maria
    Resino, Salvador
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [28] Update on hepatitis C: Direct-acting antivirals
    Seifert, Leon L.
    Perumpail, Ryan B.
    Ahmed, Aijaz
    WORLD JOURNAL OF HEPATOLOGY, 2015, 7 (28) : 2829 - 2833
  • [29] Efficacy of direct-acting antivirals on elimination of HCV and its effect on platelet in patients with chronic hepatitis C virus
    Salama, Basem M. M.
    Emola, Khaled
    Heiza, Mohamed
    MEDICAL SCIENCE, 2020, 24 (103) : 1600 - 1605
  • [30] Pangenotypic triple versus double therapy in HCV-infected patients after prior failure of direct-acting antivirals
    Flisiak, Robert
    Zarebska-Michaluk, Dorota
    Berak, Hanna
    Dybowska, Dorota
    Sitko, Marek
    Parfieniuk-Kowerda, Anna
    Janocha-Litwin, Justyna
    Janczewska, Ewa
    Piekarska, Anna
    Lorenc, Beata
    Mazur, Wlodzimierz
    Dobrowolska, Krystyna
    Tudrujek-Zdunek, Magdalena
    Klapaczynski, Jakub
    Jaroszewicz, Jerzy
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (03) : 193 - 201
12345